Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
12/2008
12/03/2008CN100439357C Benzo [b][1,4] dioxepine derivatives
12/02/2008US7459480 Benzodioxepine derivatives
11/2008
11/20/2008WO2007098139A3 Anticancer agents
11/20/2008DE102008000275A1 Alkenacetale und ihre Verwendung als Riechstoffe Alkenacetale and their use as odorants
11/19/2008EP1992606A1 Alkene acetals and their use as odorous substances
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/13/2008US20080281108 Ether cyclized and acetylene functionalized [1,1']binaphthalenyl-2,2'-diol derivatives; synthesis; electrooptical, electronic, semiconducting and/or luminescent components
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/06/2008US20080272337 Chiral Compounds
11/05/2008CN100430402C Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
11/05/2008CN100430345C Method for producing compounds having CF2O bridge
10/2008
10/30/2008US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
10/30/2008US20080269298 anticarcinogenic agent, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; for treatment of susceptible neoplasm selected from breast, colon, lung, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma, ovarian, pancreatic, head and neck
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/23/2008US20080261318 Signalling Compounds For Use In Methods Of Detecting Hydrogen Peroxide
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/01/2008CN101277943A 手性化合物 Chiral compounds
09/2008
09/24/2008CN101273111A Chiral compounds
09/18/2008US20080227851 psoriasis, eczema, multiple sclerosis, and arthritis; cross-metathesis reaction being promoted by a cross-metathesis catalyst
09/16/2008US7425356 Liquid crystalline polymers mixture:, display, optics, diagnosis
08/2008
08/28/2008US20080207926 Process for preparation of 13,14-dihydro-pgf2 alpha derivatives
08/26/2008US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma
08/26/2008US7416898 Derived from the oxidation of novel alkenes prepared by the coupling of substituted aromatic esters or ketones and spiro-fused ketones with or without a pi -electron system or a carbon-carbon double bond in the ring
08/14/2008US20080194678 Process To Obtain Synthetic And Semi-Synthetic Lignan Derivatives, Their Antiparasitic Activities And Corresponding Pharmaceutical Formulations, Including The Therapeutic Method Using Said Lignan For The Treatment Of Parasitosis
08/13/2008EP1955697A1 2-aminobenzamide derivative
08/06/2008EP1951047A2 Tyrosine kinase inhibitors
07/2008
07/30/2008CN100406006C Chromatosis remedies
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/22/2008US7402688 novel 2,2-disubstituted-19-norvitamin D derivatives and 20-epi-19-norvitamin D derivatives; metabolic regulatory hormone of calcium and phosphorus; biological activities: cellular induced differentiation, suppression of proliferation, and immunomodulation by transcription control of target gene
07/22/2008US7402670 Synthesis by chiral diamine-mediated asymmetric alkylation
07/02/2008EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
06/2008
06/25/2008CN101208346A Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors
06/24/2008US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine
06/24/2008US7390670 reacting a boronate-substituted aromatic or heteroaromatic ring compound with a peroxide source and detecting the product by measuring color, absorbance, fluorescence, chemiluminescence, or bioluminescence
06/19/2008US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension
06/19/2008US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy
06/17/2008US7388118 Amine 1,2- and 1,3-diol compounds
06/11/2008EP1928980A1 Chiral compounds
06/11/2008EP1928854A1 Chiral compounds
06/10/2008US7385067 Process for the preparation of compounds having a CF2O bridge
06/10/2008US7384980 Derivatives of 3,3-diphenylpropylamines
06/10/2008CA2146669C Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
06/05/2008US20080132581 particularly tyrosinase; preventing and treating melanin overproduction; isolated from a plant family selected from the group consisting of Compositae, Fabaceae, Lauraceae, Leguminosae, Liliaceae, Loranthaceae, Moracea, and Myristicaceae
05/2008
05/29/2008WO2008061871A1 Ketomethionine ketals and their derivatives
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008DE102006055470A1 Ketomethioninketale und deren Derivate Ketomethionine and their derivatives
05/29/2008CA2669893A1 Ketomethionine ketals and their derivatives
05/28/2008EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers
05/28/2008CN100390121C Process for producing a-methylstyrene
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/14/2008EP1664013B1 Calcilytic compounds
05/06/2008US7368608 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives
05/06/2008US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
05/06/2008US7368475 high and selective activity against Cytomegalovirus
04/2008
04/30/2008CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors
04/30/2008CN101171003A Cytokine modulators using cyclic glycerides of essential poyunsaturated fatty acids
04/29/2008US7365214 Process for the preparation of cyclic carbonates
04/23/2008CN100383143C One-pot processing method for synthesizing rifampicin
04/17/2008DE102007043921A1 Polymerizable compounds useful for making liquid crystal displays of the polymer sustained alignment type comprise polymerizable groups bonded to a biaryl structure
04/16/2008EP1911761A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof
04/16/2008EP1594855A4 Signalling compounds for use in methods of detecting hydrogen peroxide
04/16/2008CN100381424C Biaryl sulfonamides and methods for using same
04/15/2008US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts
04/15/2008CA2328920C Novel derivatives of 3,3-diphenylpropylamines
04/09/2008EP1907380A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis
04/08/2008US7354945 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements
04/01/2008US7351734 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
03/2008
03/20/2008US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure
03/18/2008CA2238365C Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
03/13/2008WO2007133352A3 Macrocyclic kinase inhibitors
03/13/2008US20080064828 Containing within molecule, a vinyl group as a reactive group in a side chain and containing a unit having an amide group and a sulfonic acid group; can be produced by reaction between a polyhydroxyalkanoate starting material and an aminosulfonic acid; biodegradable plastic; soft members for medical use
02/2008
02/27/2008CN101133044A Continuous method for the production of a dioxirane
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/13/2008EP1885728A1 Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors
02/12/2008US7329634 pesticides and herbicides; dehalogenation and reduction of 3-[(2-ethyl-4-bromo-6-methyl)phenyl]-5,5-pentamethylenepyrrolidine-2,4-dione with halogenating agent in presence of solvent and free radical initiator; animal pests and crops controlling
02/12/2008CA2532151C Nitrification inhibitors and the use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
02/07/2008US20080032964 Process for the synthesis of azetidinone
01/2008
01/23/2008EP1326855B1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
01/17/2008US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds
01/16/2008EP1487816B1 Ether lactone
01/16/2008CN101104613A Macrocyclic glyceride with oxidization resistant activity and its preparation method and use
01/15/2008US7319155 Methanesulfonic acid [7-(4-nitrophenyl)-(5H,9H)-6,8-dioxabenzocyclohepten-2-yl]methyl ester; chemical intermediates
01/09/2008CN100360477C Application of novel nitration inhibitor and polyacid in processing inorganic fertilizer containing nitration inhibitor
12/2007
12/27/2007WO2007123736A3 Processes for shaping macrocyclic oligoesters
12/27/2007WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299256 Substituted alditol compounds, compositions, and methods
12/13/2007US20070287843 Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol
11/2007
11/29/2007US20070274928 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof
11/22/2007WO2007133810A2 Methods for providing stand-in services for transaction card customization
11/22/2007US20070270485 Byrostatin analogues, synthetic methods and uses
11/21/2007EP1856086A1 Continuous method for the production of a dioxirane
11/21/2007EP1856032A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
11/15/2007US20070265333 For treatment of melanoma, colon cancer, and/or breast cancer
11/14/2007EP1853254A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/14/2007CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066967A Synthesis process of dibenzo dioxy octanone compound
11/01/2007WO2007123736A2 Processes for shaping macrocyclic oligoesters
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 21